tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT
Holding IMVT?
Track your performance easily

Immunovant (IMVT) Financial Statements

771 Followers

Immunovant Financial Overview

Immunovant's market cap is currently ―. The company's EPS TTM is $-2.215; its P/E ratio is -12.13; Immunovant is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -109.04M$ -87.07M$ -83.47M$ -61.80M$ -73.95M
EBITDA$ -108.93M$ -86.93M$ -83.15M$ -61.74M$ -73.61M
Net Income Common Stockholders$ -109.12M$ -87.15M$ -75.32M$ -58.66M$ -73.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 472.94M$ 560.00M$ 635.37M$ 269.93M$ 329.96M
Total Assets$ 515.71M$ 589.68M$ 666.37M$ 292.07M$ 351.22M
Total Debt$ 47.00K$ 69.00K$ 138.00K$ 614.00K$ 919.00K
Net Debt$ -472.89M$ -559.94M$ -635.23M$ -269.31M$ -329.04M
Total Liabilities$ 66.65M$ 45.02M$ 48.61M$ 40.26M$ 51.36M
Stockholders Equity$ 449.05M$ 544.66M$ 617.76M$ 251.81M$ 299.87M
Cash Flow-
Free Cash Flow$ -88.84M$ -76.38M$ -59.85M$ -60.09M$ -47.41M
Operating Cash Flow$ -88.65M$ -76.20M$ -59.70M$ -60.06M$ -47.37M
Investing Cash Flow$ -196.00K$ -182.00K$ -150.00K$ -34.00K$ -45.00K
Financing Cash Flow$ 730.00K$ 686.00K$ 1.54M$ 148.00K$ 890.00K
Currency in USD

Immunovant Earnings and Revenue History

Immunovant Debt to Assets

Immunovant Cash Flow

Immunovant Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis